VSee Health Statistics
Total Valuation
VSee Health has a market cap or net worth of $9.01 million. The enterprise value is $7.69 million.
Important Dates
The last earnings date was Wednesday, April 1, 2026, after market close.
| Earnings Date | Apr 1, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
VSee Health has 47.30 million shares outstanding. The number of shares has increased by 97.23% in one year.
| Current Share Class | 47.30M |
| Shares Outstanding | 47.30M |
| Shares Change (YoY) | +97.23% |
| Shares Change (QoQ) | +89.04% |
| Owned by Insiders (%) | 17.42% |
| Owned by Institutions (%) | 4.81% |
| Float | 33.58M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.66 |
| Forward PS | n/a |
| PB Ratio | 1.25 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.53 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.51, with a Debt / Equity ratio of 0.60.
| Current Ratio | 0.51 |
| Quick Ratio | 0.50 |
| Debt / Equity | 0.60 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.41 |
Financial Efficiency
Return on equity (ROE) is -541.52% and return on invested capital (ROIC) is -228.24%.
| Return on Equity (ROE) | -541.52% |
| Return on Assets (ROA) | -28.25% |
| Return on Invested Capital (ROIC) | -228.24% |
| Return on Capital Employed (ROCE) | -155.35% |
| Weighted Average Cost of Capital (WACC) | 22.97% |
| Revenue Per Employee | $94,923 |
| Profits Per Employee | -$95,538 |
| Employee Count | 154 |
| Asset Turnover | 0.69 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, VSee Health has paid $68,426 in taxes.
| Income Tax | 68,426 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -85.00% in the last 52 weeks. The beta is 0.64, so VSee Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.64 |
| 52-Week Price Change | -85.00% |
| 50-Day Moving Average | 0.27 |
| 200-Day Moving Average | 0.60 |
| Relative Strength Index (RSI) | 28.04 |
| Average Volume (20 Days) | 689,592 |
Short Selling Information
The latest short interest is 783,682, so 1.66% of the outstanding shares have been sold short.
| Short Interest | 783,682 |
| Short Previous Month | 1.01M |
| Short % of Shares Out | 1.66% |
| Short % of Float | 2.33% |
| Short Ratio (days to cover) | 1.33 |
Income Statement
In the last 12 months, VSee Health had revenue of $14.62 million and -$14.71 million in losses. Loss per share was -$0.73.
| Revenue | 14.62M |
| Gross Profit | 7.36M |
| Operating Income | -9.58M |
| Pretax Income | -14.64M |
| Net Income | -14.71M |
| EBITDA | -7.00M |
| EBIT | -9.58M |
| Loss Per Share | -$0.73 |
Full Income Statement Balance Sheet
The company has $5.27 million in cash and $3.26 million in debt, giving a net cash position of $2.01 million or $0.04 per share.
| Cash & Cash Equivalents | 5.27M |
| Total Debt | 3.26M |
| Net Cash | 2.01M |
| Net Cash Per Share | $0.04 |
| Equity (Book Value) | 5.45M |
| Book Value Per Share | 0.16 |
| Working Capital | -7.88M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$3.45 million and capital expenditures -$29,928, giving a free cash flow of -$3.48 million.
| Operating Cash Flow | -3.45M |
| Capital Expenditures | -29,928 |
| Depreciation & Amortization | 2.59M |
| Net Borrowing | 1.59M |
| Free Cash Flow | -3.48M |
| FCF Per Share | -$0.07 |
Full Cash Flow Statement Margins
Gross margin is 50.32%, with operating and profit margins of -65.55% and -100.65%.
| Gross Margin | 50.32% |
| Operating Margin | -65.55% |
| Pretax Margin | -100.18% |
| Profit Margin | -100.65% |
| EBITDA Margin | -47.85% |
| EBIT Margin | -65.55% |
| FCF Margin | n/a |